Biotech Drug Report Generated Oct 31, 2026
- Trial phase
- Not stated
- Time to market
- Not stated
⚠ Few sources Few sources were found for this drug. Treat the rating as low-confidence and verify against the cited sources.
Actionable Insight NEUTRAL
MenQuadfi is already approved and commercialized in both the US and EU. The next catalysts would be country-level reimbursement decisions and ACIP schedule updates following the infant label expansions, but these are gradual commercial events rather than binary stock-moving catalysts. Watch for Sanofi's quarterly vaccine segment sales for evidence of MenQuadfi market share gains against GSK's Menveo and Nimenrix.
Price Chart
Loading chart...
The Two-Sided Case
▲ Bull Case1
[""MenQuadfi is the first quadrivalent meningococcal conjugate vaccine approved for infants as young as 6 weeks of age in both the US (May 2025) and the EU (August 2025), expanding the addressable pediatric market significantly.", "The meningococcal vaccine market is growing at a 7-9% CAGR, with the meningitis vaccine market projected to reach USD 4.65B in 2026 growing to USD 6.61B by 2026, per Mordor Intelligence.", "MenQuadfi has WHO prequalification from the WHO, enabling procurement by UN agencies and UNICEF, opening global health organization procurement, enabling procurement by UN agencies.", "Sanofi has a strong pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with 24 in Phase 3 or submitted for approval, per its pipeline of 61 clinical-stage projects with
▼ Bear Case4
MenQuadfi competes in a concentrated market against GSK's Menveo and Nimenrix and Pfizer's Trumenba (serogroup B), limiting pricing power and share gains.
Sanofi's overall vaccine segment faced headwinds in 2025-2026, with declining immunization rates in the US and a 'soft' start to fall immunizations pressuring sales.
MenQuadfi is one of many products in Sanofi's massive portfolio (~EUR 47B revenue in 2025); even strong MenQuadfi performance has limited impact on the overall stock.
Several large institutional holders trimmed or nearly exited Sanofi positions in Q2 2026, including Barrow Hanley (-54.5%), Price T Rowe (-96.6%), and Northern Trust (-25.8%).
Source Filing
The SecBot filing or press-release report that triggered this drug report:
Sanofi 6-K SNY ·Originating report